Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Nokian’s Surpass AS01 is a new all-season tire designed with low rolling resistance and comfort in mind. That’s due, in part, to there being more silica in the rubber compound of the AS01 than ...

We sampled the AS01 on two sporty-but-not-outright-fast sedans—a Mercedes-Benz C300 and an electric Polestar 2. We then moved to a time trial run with the Surpass AS01 fitted to a Toyota GR ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their ...

The Surpass AS01 isn't the first ultra-high-performance tire from Nokian—that would be the zLine A/S—but it's the first time Nokian has offered a tire in this segment in a few years.

The Nokian Surpass AS01 is an ultra-high-performance all-season tire with a 55,000-mile warranty, designed for stability and comfort. Tested on a track, it offers predictable handling and durability.